The U.S. Centers for Disease Control and Prevention CDC updated its COVID-19 vaccination data this weekend, showing a slow but steady upward trend in cases over the past few days. At the same time, the agency also released data on U.S. vaccination rates as of late Saturday, April 17, showing that more than 205,000,000 doses of vaccine have been administered.
According to the CDC’s Vaccine Tracker website, the majority of vaccines administered in the U.S. to date have been Pfizer’s COVID-19 product, followed by Modena’s product. Johnson & Johnson’s single-dose product picked up speed quickly in the weeks following its launch, though it has hit a bit of an evaluation snag because of “extremely rare” blood clot problems.
As of April 17, more than 82 million people in the U.S. had received the new coronavirus vaccine, meaning they had received at least a single dose or one of two doses of the vaccine. In addition, more than 129 million people in the United States have received their first dose of the vaccine, meaning that it won’t be long before half of the U.S. population has some level of protection against the virus.
Nearly all of the reported vaccine doses were given to people over the age of 18, accounting for 49.7% of that population. According to the most recent data, more than 80 percent of adults 65 years and older in the United States have received at least one dose of the vaccine, and more than 65 percent have been fully vaccinated.
The CDC defines “complete protection” as the ability of the vaccine to provide protection two weeks after the second dose, which will vary somewhat depending on the type of vaccine each person receives, but all vaccines licensed for use in the United States provide a substantial degree of protection against infection and severe COVID-19.
Recent Comments